Overview Fundamentals API Earnings EOD API Sample Code Pricing

Cartesian Therapeutics Inc. (RNAC NASDAQ) stock market data APIs

$18.61 1.92(11.5%) as of July 18, 2024
Price chart is built with Anychart

Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, engages in the provision of mRNA cell therapies for the treatment of autoimmune diseases. It develops Descartes-08, an autologous anti-BCMA RNA-engineered chimeric antigen receptor T-cell therapy, currently under Phase 2b clinical development for generalized myasthenia gravis, as well as for patients with systemic lupus erythematosus, and myeloma autoimmune basket trials for other autoimmune diseases. The company develops Descartes-15 to treat Autoimmune diseases, myeloma; and Descartes-33 which is in preclinical development for treatment of autoimmune diseases. Cartesian Therapeutics, Inc. is headquartered in Gaithersburg, Maryland.

Cartesian Therapeutics Inc. Financial Data Overview

16.69
18.61
-
20.99
16.385
11.665-42.6
423 M
21 380 K
25 906 K
-10.5
0.832
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'RNAC',
Type: 'Common Stock',
Name: 'Cartesian Therapeutics Inc.',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG001J19Q25',
ISIN: NULL,
CUSIP: NULL,
CIK: '1453687',
EmployerIdNumber: '26-1622110',
FiscalYearEnd: 'December',
IPODate: '2016-06-22',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Cartesian Therapeutics Inc. Fundamental Data is available in our Financial Data APIs

  • Net Revenue 25 906 K
  • EBITDA -68 263 000
  • Earnings Per Share -56.06
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Cartesian Therapeutics Inc. Earnings via APIs

  • Latest Release 2024-05-08
  • EPS/Forecast -0.88

Get Cartesian Therapeutics Inc. End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com